芬太尼透皮贴剂用于利卡汀介入治疗肝癌患者疼痛的疗效观察

目的：探讨芬太尼透皮贴剂用于肝癌晚期患者行利卡汀介入治疗术后疼痛的疗效观察、生活质量和不良反应。 方法：临床选择60例肝癌晚期行利卡汀治疗后疼痛患者,使用芬太尼透皮贴剂止痛,进行止痛效果观察、生活质量和不良反应的分析。 结果：60例肝癌晚期患者使用芬太尼透皮贴剂后,疼痛完全缓解者40例(66%)；部分缓解者10例(16%)；轻度缓解者6例(10%)；无效果者4例(6%)。 结论： 芬太尼透皮贴剂作为长效持续止痛剂,具有镇痛效果良好、成瘾性小、不良反应轻、无创伤性和使用便捷等优点,适用于肝癌晚期行利卡汀介入治疗术后的止痛疗法。

Transdermal fentanyl for pain treatment after interventional therapy for liver cancer Iodine [[sub_s]131[sub_e]I] Metuximab Injection curative effect observation

Objective: To investigate the effect of transdermal fentanyl in patients with advanced liver cancer during interventionni treatment of postoperative pain, quality of life and clinical observation of adverse reactions. Methods: 60 cases of clinical selection of advanced liver cancer after treatment line Licartin pain patients, the use of transdermal fentanyl for pain relief, for analgesic effect, quality of life and the analysis of the bad reaction. Results: 60 cases of advanced liver cancer patients using transdermal fentanyl after complete remission rate, pain in 40 cases (66%); a partial remission rate in 10 cases (16%); a mild remission rate in 6 cases (10%); 4 (6%). Conclusion: transdermal fentanyl as a long-term sustained analgesic, has good analgesic effect, addictive little, adverse reactions are mild, noninvasive and convenient use and the like, suitable for advanced liver cancer line during interventionni treatment of postoperative pain therapy.#$NLKeywords:Transdermal fentanyl for hepatocellular carcinoma; Interventional therapy;